Rationale for an oral thrombin inhibitor from a pharmacological point of view;Rationale für einen oralen direkten thrombininhibitor aus pharmakologischer sicht

Hamostaseologie

Volumn 22, Issue 3, 2002, Pages 92-97

  Nowak, Götz ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Hirudin; Melagatran; Thrombin inhibitors; Ximelagatran

Indexed keywords

DICOUMAROL; FIBRINOPEPTIDE; HEPARIN; HIRUDIN; MELAGATRAN; THROMBIN INHIBITOR; XIMELAGATRAN;

CLINICAL TRIAL; DOSE RESPONSE; DRUG ELIMINATION; HEART DISEASE; HUMAN; PATIENT COMPLIANCE; REVIEW; STROKE; THROMBOPHILIA; THROMBOSIS;

EID: 0036373586     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619545     Document Type: Review

References (14)

1. Inhibition of thrombin and trypsin by tripeptide aldehydes
2. The refined 1.9 Å crystal structure of human α-thrombin: Interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment
3. Heparin-induced thrombocytopenia: Mechanism of interaction of the heparin-dependent antibody with platelets
4. Direct thrombin inhibitor trialists collaborative group: Direct thrombin inhibitors in acute coronary syndromes and during percutaneous coronary intervention: Design of a meta-analysis based on individual patient data
5. Recombinant hirudin (Lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia. A prospective study
6. Synthetic inhibitors of thrombin and factor Xa: From bench to bedside
7. Heparin-induced thrombocytopenia: Laboratory studies
8. Ecarin chromogenic assay (ECA) - A new chromogenic assay useful for clinical monitoring of direct thrombin inhibitors like hirudin
9. Antithrombin- und antiplasminwirkung von 4-amidinophenylbrenztraubensäure (APPA) in vivo
10. Direct thrombin inhibitors: Current status and future prospects
11. A new method for the therapeutical monitoring of hirudin
12. Prothrombin conversion intermediate effectively neutralizes toxic levels of hirudin
13. Quantitative determination of hirudin in blood and body fluids
14. Advances in the development of thrombin inhibitors